Allworth Financial’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.22K Buy
341
+40
+13% +$382 ﹤0.01% 4321
2026
Q1
$2.75K Buy
301
+25
+9% +$210 ﹤0.01% 4237
2025
Q4
$2.05K Buy
276
+58
+27% +$417 ﹤0.01% 4112
2025
Q3
$1.46K Buy
+218
New +$1.51K ﹤0.01% 4138

Other funds holding BVS

Allworth Financial's BVS Position: Q2 2026 in Review

Allworth Financial increased its Bioventus (BVS) stake by 13% in Q2 2026, buying an estimated $382 and bringing the position to 341 shares worth $3.22K. The position accounts for ﹤0.01% of the portfolio, ranked #4321.

Allworth Financial first reported a position in BVS in Q3 2025 and has held it in 4 quarters since. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Allworth Financial held 341 shares of Bioventus worth $3.22K as of Q2 2026.
  • Allworth Financial bought 40 Bioventus shares in Q2 2026, an estimated $382.
  • Bioventus made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4321 holding.
  • Allworth Financial first reported a position in Bioventus in Q3 2025 and has held it in 4 quarters since.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.